Eravacycline susceptibility was impacted by genetic mutation of 30S ribosome subunits, and branched-chain amino acid transport system II carrier protein, Na/Pi cotransporter family protein in Staphylococcus aureus

BACKGROUND: Our previous research indicated the excellent in vitro antibacterial activity of Eravacycline (Erava) and its heteroresistance frequency against clinical Staphylococcus aureus isolates. In this study, we further aimed to investigate the mechanisms of Erava resistance and heteroresistance...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:BMC Microbiol
Main Authors: Wang, Zhanwen, Lin, Zhiwei, Bai, Bing, Xu, Guangjian, Li, Peiyu, Yu, Zhijian, Deng, Qiwen, Shang, Yongpeng, Zheng, Jinxin
פורמט: Artigo
שפה:Inglês
יצא לאור: BioMed Central 2020
נושאים:
Research Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC7329441/
https://ncbi.nlm.nih.gov/pubmed/32611319
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12866-020-01869-6
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים